Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin

Crystal structures of DX9065a and a related bisamidino‐aryl inhibitor specific for the blood‐clotting factor Xa have been solved in complex with bovine β‐trypsin to a resolution of 1.9 Å. Each inhibitor exhibits an extended conformation along the active site, in contrast to the compact folded structures observed for thrombin specific inhibitors. Few direct contacts (predominantly in the S1 pocket) are made between trypsin and the inhibitors. Transfer of the inhibitors to the active site of factor Xa suggests a three‐site interaction: salt bridge formation at the base of the primary specificity pocket, extensive hydrophobic surface burial and a weak electrostatic interaction between the distal basic component of the inhibitor and an electronegative cavity of factor Xa formed by three backbone carbonyl oxygens. Additivity of these three interactions is the basis for the observed strong inhibition of factor Xa and provides a framework for the design of novel factor Xa inhibitors. A propionic acid group of the inhibitor would clash with the thrombin specific ‘60‐insertion loop’, thus conferring selectivity against thrombin.

[1]  J. Stürzebecher,et al.  Synthetic inhibitors of bovine factor Xa and thrombin comparison of their anticoagulant efficiency. , 1989, Thrombosis research.

[2]  D. Turk,et al.  Geometry of binding of the benzamidine- and arginine-based inhibitors Nα-(2-naphthyl-sulphonyl-glycyl)-dl-p-amidinophenylalanyl-piperidine (NAPAP) and (2R,4R)-4-methyl-1-[Nα-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine carboxylic acid (MQPA) to human α-thrombin , 1990 .

[3]  G. Vlasuk.  Structural and Functional Characterization of Tick Anticoagulant Peptide (TAP): A Potent and Selective Inhibitor of Blood Coagulation Factor Xa , 1993, Thrombosis and Haemostasis.

[4]  S. Kunitada,et al.  Molecular model of an interaction between factor Xa and DX-9065a, a novel factor Xa inhibitor: Contribution of the acetimidoylpyrrolidine moiety of the inhibitor to potency and selectivity for serine proteases , 1995 .

[5]  Robert Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989 .

[6]  H. Umeyama,et al.  X-ray analysis of a thrombin inhibitor-trypsin complex. , 1989, Journal of biochemistry.

[7]  R. Huber,et al.  Accurate Bond and Angle Parameters for X-ray Protein Structure Refinement , 1991 .

[8]  Wolfgang Kabsch,et al.  Evaluation of Single-Crystal X-ray Diffraction Data from a Position-Sensitive Detector , 1988 .

[9]  H. Ishihara,et al.  DX-9065a, a New Synthetic, Potent Anticoagulant and Selective Inhibitor for Factor Xa , 1994, Thrombosis and Haemostasis.

[10]  Michael E. Johnson,et al.  Proposed cation‐π mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognition , 1995, FEBS letters.

[11]  S. Katakura,et al.  Dibasic (amidinoaryl)propanoic acid derivatives as novel blood coagulation factor Xa inhibitors. , 1994, Journal of medicinal chemistry.

[12]  H Oschkinat,et al.  The interaction of thrombin with fibrinogen. A structural basis for its specificity. , 1992, European journal of biochemistry.

[13]  D. Turk,et al.  Geometry of binding of the N alpha-tosylated piperidides of m-amidino-, p-amidino- and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes. , 1991, FEBS letters.

[14]  J. Walter,et al.  The X-ray crystal structure analysis of the refined complex formed by bovine trypsin and p-amidinophenylpyruvate at 1.4 A resolution. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[15]  R. Tidwell,et al.  Strategies for anticoagulation with synthetic protease inhibitors. Xa inhibitors versus thrombin inhibitors. , 1980, Thrombosis research.

[16]  S. Katakura,et al.  A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin. , 1993, Biochemical and biophysical research communications.

[17]  H Brandstetter,et al.  Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. , 1992, Journal of molecular biology.

[18]  R. Huber,et al.  Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.

[19]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[20]  W. Bode,et al.  The clot thickens: clues provided by thrombin structure. , 1995, Trends in biochemical sciences.

[21]  W. Bode,et al.  Crystal structures of thrombin and thrombin complexes as a framework for antithrombotic drug design , 1994 .

[22]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[23]  D. Banner,et al.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. , 1994, The Journal of biological chemistry.

[24]  C. Dunwiddie,et al.  Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa. , 1991, Archives of biochemistry and biophysics.

[25]  Robert Huber,et al.  On the disordered activation domain in trypsinogen: chemical labelling and low‐temperature crystallography , 1982 .

[26]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.